JP2005525089A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005525089A5 JP2005525089A5 JP2003552801A JP2003552801A JP2005525089A5 JP 2005525089 A5 JP2005525089 A5 JP 2005525089A5 JP 2003552801 A JP2003552801 A JP 2003552801A JP 2003552801 A JP2003552801 A JP 2003552801A JP 2005525089 A5 JP2005525089 A5 JP 2005525089A5
- Authority
- JP
- Japan
- Prior art keywords
- producing
- pharmaceutically acceptable
- pharmaceutical composition
- acceptable carrier
- antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003937 drug carrier Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 206010003816 Autoimmune disease Diseases 0.000 claims 1
- 206010060945 Bacterial infection Diseases 0.000 claims 1
- 206010047461 Viral infection Diseases 0.000 claims 1
- 208000001756 Virus Disease Diseases 0.000 claims 1
- 230000003042 antagnostic Effects 0.000 claims 1
- 239000005557 antagonist Substances 0.000 claims 1
- 201000009596 autoimmune hypersensitivity disease Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 200000000018 inflammatory disease Diseases 0.000 claims 1
- 230000017613 viral reproduction Effects 0.000 claims 1
Claims (1)
- 自己免疫疾患、炎症性疾患、癌、又は細菌及びウィルス感染を治療するための医薬組成物を製造する方法であって、請求項１〜１１のいずれか１項に記載のCC-ケモカインのアンタゴニストを、医薬として許容されるキャリアと合体することを含む、医薬組成物の製造方法。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01000761 | 2001-12-17 | ||
| PCT/EP2002/014325 WO2003051921A1 (en) | 2001-12-17 | 2002-12-16 | Chemokine mutants acting as chemokine antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005525089A JP2005525089A (ja) | 2005-08-25 |
| JP2005525089A5 true JP2005525089A5 (ja) | 2006-01-05 |
Family
ID=8176112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003552801A Pending JP2005525089A (ja) | 2001-12-17 | 2002-12-16 | ケモカイン・アンタゴニストとして作用するケモカイン突然変異体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7553483B2 (ja) |
| EP (1) | EP1458756B1 (ja) |
| JP (1) | JP2005525089A (ja) |
| AT (1) | ATE421974T1 (ja) |
| AU (1) | AU2002358144B2 (ja) |
| CA (1) | CA2468790A1 (ja) |
| DE (1) | DE60231057D1 (ja) |
| ES (1) | ES2320743T3 (ja) |
| IL (1) | IL162600A0 (ja) |
| WO (1) | WO2003051921A1 (ja) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7476381B2 (en) | 2002-12-23 | 2009-01-13 | Laboratoires Serono Sa | Methods of reducing serum alanine transferase levels in a subject with hepatitis |
| EP1439191B1 (en) * | 2004-01-19 | 2006-04-05 | Ares Trading S.A. | Process for the purification of bacterially expressed proteins |
| US8445442B2 (en) | 2007-04-26 | 2013-05-21 | University Of Vermont And State Agricultural College | CCL18 and CCL3 methods and compositions for detecting and treating cancer |
| AU2008317495B2 (en) | 2007-08-02 | 2013-08-01 | Novimmune S.A. | Anti-RANTES antibodies and methods of use thereof |
| WO2010071610A1 (en) * | 2008-12-19 | 2010-06-24 | Agency For Science, Technology And Research (A*Star) | Severe chikungunya biomarkers |
| EP2380975A1 (de) * | 2010-04-22 | 2011-10-26 | Scil Proteins GmbH | Verfahren zur Herstellung von rekombinantem Thrombin |
| US9717777B2 (en) | 2010-05-05 | 2017-08-01 | Rappaport Family Institute For Research In The Medical Sciences | Use of CCL1 in therapy |
| EP2566500B1 (en) * | 2010-05-05 | 2017-04-12 | Rappaport Family Institute for Research in the Medical Sciences | Ccl1 for use in therapy |
| EP3307330B1 (en) * | 2015-06-15 | 2021-03-10 | New York University | Method of treatment using oncolytic viruses |
| WO2017077062A1 (en) * | 2015-11-05 | 2017-05-11 | Ludwig-Maximilians-Universität München | A peptide derived from human neutrophile peptide 1 |
| KR102682118B1 (ko) * | 2016-04-29 | 2024-07-08 | 주식회사유한양행 | Ccl3 변이체를 포함하는 융합 단백질 및 이의 용도 |
| CN118556073A (zh) | 2021-10-06 | 2024-08-27 | 维罗治疗有限公司 | 新型免疫调节剂 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07502404A (ja) * | 1991-12-23 | 1995-03-16 | ブリティッシュ バイオ−テクノロジー リミテッド | 幹細胞阻害タンパク質 |
| AU688641B2 (en) * | 1994-12-08 | 1998-03-12 | Glaxo Group Limited | Rantes peptide and fragments and compositions comprising it for treatment of inflammation |
| JP2001506492A (ja) * | 1996-12-05 | 2001-05-22 | ヒューマン ゲノム サイエンシズ インク． | ヒトケモカインβ−１３ |
| EP0949271A1 (en) * | 1996-12-05 | 1999-10-13 | Kyowa Hakko Kogyo Co., Ltd. | Novel dna, novel protein, and novel antibody |
| EP0906954A1 (en) | 1997-09-29 | 1999-04-07 | Applied Research Systems ARS Holding N.V. | Amino-terminal truncated c-c chemokines as chemokine antagonist |
| ES2247738T3 (es) | 1997-12-23 | 2006-03-01 | Fondazione Centro San Raffaele Del Monte Tabor | Mutantes de rantes y sus aplicaciones terapeuticas. |
| JPH11243960A (ja) | 1998-03-06 | 1999-09-14 | Shionogi & Co Ltd | ヒトｃｃ型ケモカインエオタキシン３ |
| DK1346731T3 (da) * | 1998-07-22 | 2007-04-10 | Osprey Pharmaceuticals Ltd | Konjugater til behandling af inflammatoriske forstyrrelser og tilsvarende vævsskade |
| WO2000078334A1 (en) * | 1999-06-17 | 2000-12-28 | University Of Maryland Biotechnology Institute | Chimeric chemokine-antigen polypeptides and uses therefor |
| AU2001266557A1 (en) | 2000-04-12 | 2001-10-23 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| UA77950C2 (en) | 2000-10-04 | 2007-02-15 | Applied Research Systems | Use of mutants of cc chemokines for treatment of multiple sclerosis |
-
2002
- 2002-12-16 AU AU2002358144A patent/AU2002358144B2/en not_active Ceased
- 2002-12-16 CA CA002468790A patent/CA2468790A1/en not_active Abandoned
- 2002-12-16 EP EP02791832A patent/EP1458756B1/en not_active Expired - Lifetime
- 2002-12-16 JP JP2003552801A patent/JP2005525089A/ja active Pending
- 2002-12-16 WO PCT/EP2002/014325 patent/WO2003051921A1/en active Application Filing
- 2002-12-16 US US10/499,100 patent/US7553483B2/en not_active Expired - Fee Related
- 2002-12-16 DE DE60231057T patent/DE60231057D1/de not_active Expired - Lifetime
- 2002-12-16 AT AT02791832T patent/ATE421974T1/de not_active IP Right Cessation
- 2002-12-16 IL IL16260002A patent/IL162600A0/xx unknown
- 2002-12-16 ES ES02791832T patent/ES2320743T3/es not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2017047I1 (no) | Tofacitinib, evt. i form av et farmasøytisk akseptabelt salt, inkludert citratsalt | |
| JP2006516528A5 (ja) | ||
| DE50102597D1 (de) | Arzneimittel gegen virale erkrankungen | |
| JP2007523135A5 (ja) | ||
| JP2003503454A5 (ja) | ||
| JP2005525089A5 (ja) | ||
| EG25011A (en) | Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments. | |
| JP2006503588A5 (ja) | ||
| JP2004532810A5 (ja) | ||
| JP2004523498A5 (ja) | ||
| JP2004529078A5 (ja) | ||
| JP2002506648A5 (ja) | ||
| JP2004538039A5 (ja) | ||
| JP2004525194A5 (ja) | ||
| JP2005501039A (ja) | 可変放出割合を持つ薬剤制御放出システム | |
| WO2004011611A3 (en) | Taci antibodies and uses thereof | |
| IL168266A (en) | Nucleoside derivatives, processes for their preparation. pharmaceutical compositions comprising them and uses thereof for the manufacture of medicaments | |
| JP2005518413A5 (ja) | ||
| JP2005538045A5 (ja) | ||
| JP2006517944A5 (ja) | ||
| JP2007501782A5 (ja) | ||
| JP2003213455A5 (ja) | ||
| ITMI20022292A1 (it) | 9a-azalidi ad attivita' antiinfiammatoria. | |
| HUP0401805A2 (hu) | Pulmonális betegségek kezelésére szolgáló vegyületek | |
| JP2004529205A5 (ja) |